In newly diagnosed polymyalgia rheumatica, weekly methotrexate improved glucocorticoid-free remission rates at 1 y | Synapse
April 10, 2026
In newly diagnosed polymyalgia rheumatica, weekly methotrexate improved glucocorticoid-free remission rates at 1 y
Key Points
This research aims to evaluate the impact of weekly methotrexate on glucocorticoid-free remission rates in patients with newly diagnosed polymyalgia rheumatica.
Evaluated newly diagnosed patients with polymyalgia rheumatica
Administered weekly methotrexate
Tracked remission rates over one year
Increased glucocorticoid-free remission rates after one year
Improved management outcomes for polymyalgia rheumatica patients
Abstract
GIM/FP/GP:Formula: see text Rheumatology:Formula: see text.